HOME



Wednesday, 8 September 2010
Novogen agrees to sell its Intellectual Property Portfolio to its subsidiary Marshall Edwards

More news

 

Back Print ASX Releases
Interview with Novogen's CEO Mr Christopher Naughton

Listen to this interview online. <a target="_blank" href="http://www.brr.com.au/event/44228">Click here to start the interview broadcast</a>
  Top Print

 

 





About Novogen | Knowledge Base | Consumer Health | Pharmaceuticals | News | Investor Relations | Contact | Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including Promensil and Trinovin | Web Design by Newgency